Blog

The Alliance’s blog offers a personal, inside look at our activities and perspectives on a range of timely issues. We encourage your feedback.

BACK TO BLOG

Author: Dan Perry

Date: June 30th, 2011

On June 26, 2011 I was interviewed by BioCentury This Week to share the Alliance for Aging Research’s impressions on the fifth reauthorization of the Food and Drug Administration’s Prescription Drug User Fee program. Thanks to Congress, we and other active patient groups were able to lend an early voice in helping to shape how user fees might be used to help speed the delivery of better treatments and cures to patient in need of relief from Alzheimer’s, Cancer, Parkinson’s and many more diseases.

As you’ll see from the segments below, we believe that the FDA heard the calls from the patient community loud and clear. Many elements that are slated to receive support from user fees can have a meaningful impact on the future availability of beneficial therapies for unserved patient populations. However, some other groups involved in the reauthorization process do not feel their voices resonated as much. They will take their cases to Congress in hopes that their agendas will become a part of the bill required to renew this program. In evaluating these policy agendas we urge members of Congress to contemplate why these agendas were not incorporated along with that of patients in the reauthorization process already. In doing so we hope that Congress will recognize the real purpose of the user fee program-it is to ensure the timely review of products submitted to the FDA. Remembering this will not only enable FDA to do its job more effectively, but it will also benefit patients.






A Tribute to a Great Scientist

Author: Dan Perry

Date: March 11th, 2008

FDA Needs More Funding to Fulfill Its Mission

Author: Cynthia Bens

Date: March 18th, 2008

Spending or Investing? -- The Silver Book & Innovation

Author: Lindsay Clarke

Date: March 26th, 2008

Preventing the Flu: A Q & A with Dr. William Schaffner

Author: Noel Lloyd

Date: December 4th, 2017

A Recap of the Clinical Trials for Alzheimer’s Disease Conference

Author: Phyllis Greenberger

Date: December 1st, 2017

An Update on the Clinical Trials for Alzheimer’s Disease Conference

Author: Noel Lloyd

Date: November 7th, 2017

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It